Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 33, Issue 11, November 2008, Pages 921-1004
 
MONOGRAPHS
 
  
 Atacicept.
Recombinant fusion protein, Oncolytic.
Vasiliou, S.
Drugs Fut 2008, 33(11): 921
Summary | Full Text: HTMLPDF 
 
  
  
 Rivoglitazone Hydrochloride.
PPARγ agonist, Insulin sensitizer, Treatment of diabetes.
Davies, S., Castaner, R., Bolos, J.
Drugs Fut 2008, 33(11): 926
Summary | Full Text: HTMLPDF 
 
  
  
 SNS-032.
Cyclin-dependent kinase inhibitor, Oncolytic.
Vasiliou, S., Castaner, R., Bolos, J.
Drugs Fut 2008, 33(11): 932
Summary | Full Text: HTMLPDF 
 
  
  
 Taspoglutide.
GLP-1 analogue, Treatment of diabetes.
Arjona, A.
Drugs Fut 2008, 33(11): 938
Summary | Full Text: HTMLPDF 
 
  
 
REVIEW ARTICLES
 
  
 Natural tyrosinase inhibitors for skin hyperpigmentation.
Alexandre Nesterov, Jifu Zhao, Qi Jia
Drugs Fut 2008, 33(11): 945
Full Text: HTMLPDF 
 
  
  
 Role of hepatocyte growth factor in heart failure: from therapeutic potential to prognosis assessment.
Yang, Z.-J., Wang, W.
Drugs Fut 2008, 33(11): 955
Full Text: HTMLPDF 
 
  
 
FILLING THE GAPS IN DRUG THERAPY
 
  
 Latent autoimmune diabetes in adults (LADA).
Ferrer, E., Dulsat, C.
Drugs Fut 2008, 33(11): 963
Summary | Full Text: HTMLPDF 
 
  
 
TARGETS TO WATCH
 
  
 Glycinamide ribonucleotide transformylase (GAR TFase) as a target for cancer therapy.
DeMartino, J.K., Boger, D.L.
Drugs Fut 2008, 33(11): 969
Summary | Full Text: HTMLPDF 
 
  
  
 Therapeutic targets for schizophrenia.
D'Agostini, A., Bozzo, J.
Drugs Fut 2008, 33(11): 981
Summary | Full Text: HTMLPDF 
 
  
 
MEETING REPORT
 
  
 Highlights from the 236th American Chemical Society (ACS) National Meeting & Exposition.
I. Izco-Basurko, P. Cole, D. Mormeneo
Drugs Fut 2008, 33(11): 991
Full Text: HTMLPDF 
 
  
 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy